Trovagene Reports Fourth Quarter and Year End 2016 Financial Results

Go back to Trovagene Reports Fourth Quarter and Year End 2016 Financial Results

Trovagene (TROV) Misses Q4 EPS by 2c

March 15, 2017 4:04 PM EDT

Trovagene (NASDAQ: TROV) reported Q4 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).

Trovagene reported a net loss of $8.5 million, or $0.34 per diluted share, as compared to a net loss of $10.2 million for the third quarter of 2016, and a net loss of... More